Evidence map›Paper›PMID 38758999›Full record

ArticleJournal of Alzheimer's disease : JAD2024

Associations of Allostatic Load with Level of and Change in Cognitive Function Among Middle-Aged and Older Hispanic/Latino Adults: The Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).

Mayra L Estrella, Wassim Tarraf, Sayaka Kuwayama, Linda C Gallo, Christian R Salazar, Ariana M Stickel, Josiemer Mattei, Priscilla M Vásquez, Kamal M Eldeirawi, Krista M Perreira and 7 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mayra L EstrellaRush Alzheimer's Disease Center and the Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
Wassim TarrafInstitute of Gerontology and Department of Healthcare Sciences, Wayne State University, Detroit, MI, USA.
Sayaka KuwayamaDepartment of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of California, San Diego, San Diego, CA, USA.
Linda C GalloDepartment of Psychology, San Diego State University, San Diego, CA, USA.
Christian R SalazarUniversity of California Irvine Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA, USA.
Ariana M StickelDepartment of Psychology, San Diego State University, San Diego, CA, USA.
Josiemer MatteiDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Priscilla M VásquezDepartment of Urban Public Health, Charles R. Drew University of Science and Medicine, Los Angeles, CA, USA.
Kamal M EldeirawiDepartment of Population Health Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA.
Krista M PerreiraDepartment of Social Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Frank J PenedoDepartment of Psychology and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Carmen R IsasiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Jianwen CaiDepartment of Biostatistics, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
Donglin ZengDepartment of Biostatistics, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
Hector M GonzálezDepartment of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of California, San Diego, CA, USA.
Martha L DaviglusInstitute for Minority Health Research, University of Illinois at Chicago, Chicago, IL, USA.
Melissa LamarInstitute for Minority Health Research, University of Illinois at Chicago, Chicago, IL, USA.

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
SDSU FUERTE: Recognition of Excellence in DEIA and Mentorship in support of Faculty SuccessU54CA267789 · NCI · SAN DIEGO STATE UNIVERSITY · PI Mark Brian Reed, Maria Luisa Zuniga de Nuncio · 2021 to 2026
$15.5M
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for ProgressP30AG059305 · NIA · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI Eron Grant Manusov · 2018 to 2026
$5.8M
Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)R01AG048642 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GONZALEZ, HECTOR M · 2015 to 2019
$5.7M
Culturally relevant contributors to cognitive and MRI changes in older LatinosR01AG062711 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI LAMAR, MELISSA · 2020 to 2025
$3.6M
Thalassemia Clinical Research Network, CanadaU01HL065233 · NHLBI · UNIVERSITY HEALTH NETWORK · PI OLIVIERI, NANCY F · 2000 to 2009
$2.6M
Early and life course socioeconomic adversity and dementia risk in Hispanics/LatinosRF1AG077639 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI DECARLI, CHARLES, GONZALEZ, HECTOR M · 2022 to 2023
$1.9M
GENETIC ARCHITECTURE OF PLASMA T-PA AND PAI-1R01HL065234 · NHLBI · VANDERBILT UNIVERSITY · PI MOORE, JASON H. · 2000 to 2004
$1.7M
Semiparametric Regression Analysis of Interval-Censored Data in Current Cohort StudiesR01HL173128 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Donglin Zeng · 2024 to 2026
$1.2M
Risk Factors for Alzheimer's Disease Among Latinos: Relationships Between Cardiovascular Disease Risk, Acculturation, Small Vessel Disease, and Alzheimer's BiomarkersK08AG075351 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ariana Stickel · 2022 to 2026
$770k
Improving Hispanic/Latino participation in preclinical Alzheimers disease TrialsK01AG076811 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christian R Salazar · 2022 to 2026
$681k
Protective Factors of Cognitive Aging among Latinos in the 50 States and Puerto RicoK01AG075353 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Mayra Lorell Estrella · 2022 to 2026
$593k
NCI NIH HHS U54 CA267789NHGRI NIH HHS HHSN268201300003CNHLBI NIH HHS HHSN268201300001CNHLBI NIH HHS HHSN268201300003INHLBI NIH HHS HHSN268201300004CNHLBI NIH HHS N01 HC065233NHLBI NIH HHS N01 HC065234NHLBI NIH HHS N01 HC065235NHLBI NIH HHS N01 HC065236NHLBI NIH HHS N01 HC065237NHLBI NIH HHS R01 HL173128NIA NIH HHS K01 AG075353NIA NIH HHS K01 AG076811NIA NIH HHS K08 AG075351NIA NIH HHS L30 AG074401NIA NIH HHS P30 AG059305NIA NIH HHS P30 AG062429NIA NIH HHS R01 AG048642NIA NIH HHS R01 AG062711NIA NIH HHS RF1 AG077639NIMHD NIH HHS L60 MD015551
6 · The paper itself

Abstract

Background: Higher allostatic load (AL), a multi-system measure of physiological dysregulation considered a proxy for chronic stress exposure, is associated with poorer global cognition (GC) in older non-Hispanic white adults. However, evidence of these associations in middle-aged and older US-based Hispanic/Latino adults is limited. Objective: To examine associations of AL with level of cognition, performance in cognition 7 years later, and change in cognition over 7 years among middle-aged and older US-based Hispanic/Latino adults. Methods: We used data (n = 5,799, 45-74 years at baseline) from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and SOL-Investigation of Neurocognitive Aging (SOL-INCA). The AL score comprised 16 biomarkers representing cardiometabolic, glucose, cardiopulmonary, parasympathetic, and inflammatory systems (higher scores = greater dysregulation). Cognitive outcomes included GC and individual tests of verbal learning and memory, world fluency (WF), Digit Symbol Substitution (DSS), and Trail Making (Parts A & B). Survey-linear regressions assessed associations of AL with performance in cognition at baseline, 7 years later, and via 7-year cognitive change scores adjusting for sociodemographic characteristics, lifestyle factors, and depressive symptoms. Results: Higher AL was associated with lower baseline performance in GC and WF; and lower 7-year follow-up performance in these same measures plus DSS and Trail Making Parts A & B. Higher AL was associated with more pronounced 7-year change (reduction) in GC and on WF and DSS tests. Conclusions: Findings extend previous evidence in predominantly older non-Hispanic white cohorts to show that AL is related to level of and change in GC (as well as WF and DSS) among middle-aged and older US-based Hispanic/Latino adults.

Indexed as

AllostasisCognitionHispanic or LatinoNeuropsychological TestsAgedAgingBiomarkersCognitive AgingCognitive DysfunctionFemaleHumansMaleMiddle AgedUnited StatesBiomarkersAllostatic loadAlzheimer’s diseasecognitive functionHispanic/Latino

Identifiers

PMID38758999
PMCPMC11343490

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.